| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/07/2007 | CN1925845A Powdered compositions of sensitive active materials in an at least partially amorphous state |
| 03/07/2007 | CN1925843A Methods and compositions for the production of monoclonal antibodies |
| 03/07/2007 | CN1924021A Gene recombination humanized pigment epithelium derivative factor and application therof |
| 03/07/2007 | CN1924015A Important regulation albumen ChK2 of NF-KB signal path |
| 03/07/2007 | CN1924013A Prourokinase modifier, preparation method, pharmaceutical composition, use, encoding gene, carrier containing gene and transformation cell |
| 03/07/2007 | CN1924012A Preparation method for rennin |
| 03/07/2007 | CN1924006A Anti-glioma peptide of scorpion, preparation method and application thereof |
| 03/07/2007 | CN1923797A Pharmaceutical compounds |
| 03/07/2007 | CN1923277A Application of protease inhibitor for protecting hepatocyte function |
| 03/07/2007 | CN1923276A Important regulation protein PAK7 of NF[kappa]B signal path |
| 03/07/2007 | CN1923254A Sheep placenta peptide preparation for promoting tissue renovation and preparing method thereof |
| 03/07/2007 | CN1923214A Preparation of sheep placenta peptide |
| 03/07/2007 | CN1923187A Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 03/07/2007 | CN1303220C Method for diagnosing and curing dentinogenesis imperfacta type II by using dentin salivary phosphoprotein gene and its coded product |
| 03/07/2007 | CN1303209C Synthetase-1b for human cholesterol ester and coded sequence |
| 03/07/2007 | CN1303208C Extraction method for SOD complex enzyme coarse powder from corn |
| 03/07/2007 | CN1303103C Transmembrane NFAT inhibitory peptide |
| 03/07/2007 | CN1303102C Method for diagnosing and curing alopecia utilizing the Rhor gene of human and rat and the encoding products |
| 03/07/2007 | CN1303101C Small peptide sequence of combined site between envelope protein E2 of close hepatitis C virus and human CD81 |
| 03/07/2007 | CN1303099C Ganoderma tsugae-proteoglycan mixture and its preparing method and use |
| 03/07/2007 | CN1302809C Nanometer granule prepn of bufanin albumin and its prepn process |
| 03/07/2007 | CN1302808C Nanometer granule prepn of cinobufagin toxoprotein and its prepn process |
| 03/07/2007 | CN1302807C Biological degradable macromolecule microspheres of carrying insulin and preparation method |
| 03/07/2007 | CN1302806C Use of LH in controlled ovarian hyperstimulation |
| 03/07/2007 | CN1302783C Oral taking preparation for aesthetic health care and preparation method |
| 03/07/2007 | CN1302776C Peptide arginals and methods for treating disseminated intravascular coagulation |
| 03/07/2007 | CN1302766C Method for preparing biological degradable polymer drug-carried fine particle by supercritical anti-solvent process |
| 03/06/2007 | US7186870 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 03/06/2007 | US7186859 Uses for amino acid anticonvulsants |
| 03/06/2007 | US7186855 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release |
| 03/06/2007 | US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 03/06/2007 | US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors |
| 03/06/2007 | US7186810 Modified peptides as therapeutic agents |
| 03/06/2007 | US7186809 Methods and compositions relating to anti-interleukin-4 receptor antibodies |
| 03/06/2007 | US7186806 Process for producing regenerated collagen fiber and process for setting the same |
| 03/06/2007 | US7186805 Fusion proteins; for inhibition of cognate receptor |
| 03/06/2007 | US7186804 IL-2 fusion proteins with modulated selectivity |
| 03/06/2007 | US7186803 Human vanilloid receptor VR3 protein |
| 03/06/2007 | US7186802 Membrane proteins; for treatment of inflammation, asthma, allergy, metastasis of cancer cells, ion transport disorders such as magnesium defects in the kidney, and inflammatory bowel disease |
| 03/06/2007 | US7186799 Binding amine to polypeptide; analyzing, calibration |
| 03/06/2007 | US7186798 Derived from ghrelin polypeptide, labelled with fluorochrome and cysteine; drug screening; high throughput assay |
| 03/06/2007 | US7186797 Stability in blood ; complexing using compound containing phosphate group |
| 03/06/2007 | US7186796 Method for drying water-borne materials |
| 03/06/2007 | US7186795 Lactoferricin gene and transformant expressing lactoferricin |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186747 enzyme inhibitors comprising heterocyclic amides, used for prevention of viral diseases |
| 03/06/2007 | US7186715 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 03/06/2007 | US7186713 Farnesyl dibenzodiazepinones and methods of treating cancer using same |
| 03/06/2007 | US7186703 Derivatives of branched-chain lipophilic molecules and uses thereof |
| 03/06/2007 | US7186700 Administering a beta -L-2'-deoxynucleoside or its pharmaceutically acceptable salt, ester or prodrug therapy of a host infected with a drug-resistant form of HBV that exhibits a mutation at the 552 codon from methionine to valine in the DNA polymerase region |
| 03/06/2007 | US7186698 Focusing ultrasonic frequency; magnetic resonance imaging |
| 03/06/2007 | US7186695 Administering organic arsenic compounds such as 4-(N-(S-glutathionylacetyl)amino)phenylarsenoxide for prophylaxis of degenarative joint disease; antiarthritic agents |
| 03/06/2007 | US7186694 Modulation body weights; dietetics; eating disorders |
| 03/06/2007 | US7186693 Metalloproteinase inhibitors for wound healing |
| 03/06/2007 | US7186692 adminstering peptide YY, Neuropeptide Y, or Pancreatic polypeptide with solubilizing agent (cyclodextran), chelating agent (ethylenediamine tetraacetic acid), and polyol such as sucrose |
| 03/06/2007 | US7186691 Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity |
| 03/06/2007 | US7186690 Method for attaching two surfaces to each other using a bioadhesive polyphenolic protein and periodate ions |
| 03/06/2007 | US7186689 Aftertreatment hip replacement; prevention forming extra bones |
| 03/06/2007 | US7186688 Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2 |
| 03/06/2007 | US7186687 for topical administration of peptide copper complex with corticosteroids, coal tar, anthralin, calcipotriene, and tazarotene; dermatology; cosmetics |
| 03/06/2007 | US7186686 Formulated composition |
| 03/06/2007 | US7186684 Hemostatic device containing a protein precipitate |
| 03/06/2007 | US7186683 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
| 03/06/2007 | US7186682 Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 03/06/2007 | US7186681 Methods of modulating cell migration using galectin-3 |
| 03/06/2007 | US7186564 Polynucleotides encoding novel cysteine proteases of the calpain superfamily, CAN-12v1 and CAN-12v2. |
| 03/06/2007 | US7186556 Modulating transcription of genes in vascular cells |
| 03/06/2007 | US7186545 Probiotic strains from Lactobacillus salivarius and antimicrobial agents obtained therefrom |
| 03/06/2007 | US7186529 Genetic engineered human cell contains an endogenous EPO (erythropoietin) gene in linkage with a heterologous viral promoters, SV40 or Cytomegalo virus |
| 03/06/2007 | US7186528 Method for preparing a physiologically active IL-18 polypeptide |
| 03/06/2007 | US7186527 Goodpasture antigen binding protein |
| 03/06/2007 | US7186526 Useful in effecting accelerated healing of wounds, bone fractures, burn tissue, damaged myocardial tissue, degenerated neurological tissue, or other trauma |
| 03/06/2007 | US7186514 Nucleotide sequences coding tumor marker protein for use in diagnosis and/or prognosis of cell proliferative disorders |
| 03/06/2007 | US7186511 Oxidase |
| 03/06/2007 | US7186503 Compounds and methods for modulating activation of NF-κB |
| 03/06/2007 | US7186425 Administering phytic acid reduced soybean protein |
| 03/06/2007 | US7186420 for an extracorporeal blood treatment; first aqueous substitution infusion fluid comprising electrolytes but excluding magnesium and calcium, and; a infusion fluid comprising calcium ions and magnesium ions. |
| 03/06/2007 | US7186418 Composition and use of RAR antagonists for promoting chondrogenesis |
| 03/06/2007 | US7186414 Improved bioavailability; for oral and intracolonic administration |
| 03/06/2007 | US7186413 Hydrogels and water soluble polymeric carriers for drug delivery |
| 03/06/2007 | US7186412 Fusion proteins of Mycobacterium tuberculosis |
| 03/06/2007 | US7186409 Neural stem cells and use thereof for brain tumor therapy |
| 03/06/2007 | US7186408 Immunomodulators; for treatment of inflammation |
| 03/06/2007 | US7186407 Including claudication and critical limb ischemia, by administering fibroblast growth factor (FGF) in two doses, a single dose administered into each leg of the patient within one hour |
| 03/06/2007 | US7186401 comprises magnesium stearate for improved storage stability; inhalers |
| 03/06/2007 | US7185647 Determination of smoothness of canisters containing inhalable medicaments |
| 03/06/2007 | CA2518298A1 Biodegradable polymers, their preparation and their use for the manufacture of bandages |
| 03/06/2007 | CA2353847C Pulmonary drug delivery |
| 03/06/2007 | CA2219132C Nucleosides with anti-hepatitis b virus activity |
| 03/06/2007 | CA2141670C Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 03/06/2007 | CA2132833C Hepatitis vaccines containing 3-o-deacylated monophosphoryl lipid a |
| 03/06/2007 | CA2128142C Pharmaceutical combination containing ras inhibitor and endothelin antagonist for the treatment of cardiovascular disorders |
| 03/01/2007 | WO2007025249A2 Methods for treatment of headaches by administration of oxytocin |
| 03/01/2007 | WO2007025247A2 Transglutaminase inhibitors and methods of use thereof |
| 03/01/2007 | WO2007025219A2 Nogo receptor polypeptides and polypeptide fragments and uses thereof |
| 03/01/2007 | WO2007024921A2 Combination therapies for inhibiting integrin-extracellular matrix interactions |
| 03/01/2007 | WO2007024899A2 Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes |
| 03/01/2007 | WO2007024817A2 Soluble fibrin inhibitory peptides and uses thereof |
| 03/01/2007 | WO2007024672A1 Use of a botulinum toxin to improve gastric emptying and/or to treat gerd |
| 03/01/2007 | WO2007024628A2 Ply-gbs mutant lysins |